| Treatment of Fabry’s disease with the pharmacologic chaperone migalastat DP Germain, DA Hughes, K Nicholls, DG Bichet, R Giugliani, WR Wilcox, ... New england journal of medicine 375 (6), 545-555, 2016 | 587 | 2016 |
| Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study DA Hughes, K Nicholls, SP Shankar, G Sunder-Plassmann, D Koeller, ... Journal of medical genetics 54 (4), 288-296, 2017 | 429 | 2017 |
| Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families LS Sullivan, SJ Bowne, DG Birch, D Hughbanks-Wheaton, ... Investigative ophthalmology & visual science 47 (7), 3052-3064, 2006 | 326 | 2006 |
| Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines MEM Pierpont, PL Magoulas, S Adi, MI Kavamura, G Neri, J Noonan, ... Pediatrics 134 (4), e1149-e1162, 2014 | 193 | 2014 |
| Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial PK Mistry, E Lukina, HB Turkia, D Amato, H Baris, M Dasouki, M Ghosn, ... Jama 313 (7), 695-706, 2015 | 169 | 2015 |
| Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care D Dimmock, S Caylor, B Waldman, W Benson, C Ashburner, ... The American Journal of Human Genetics 108 (7), 1231-1238, 2021 | 152 | 2021 |
| Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy SP Shankar, JH Fingert, V Carelli, ML Valentino, TM King, SP Daiger, ... Ophthalmic genetics 29 (1), 17-24, 2008 | 135 | 2008 |
| Fabry disease in infancy and early childhood: a systematic literature review DA Laney, DS Peck, AM Atherton, LP Manwaring, KM Christensen, ... Genetics in Medicine 17 (5), 323-330, 2015 | 117 | 2015 |
| Costello syndrome: Clinical phenotype, genotype, and management guidelines KW Gripp, LA Morse, M Axelrad, KC Chatfield, A Chidekel, W Dobyns, ... American Journal of Medical Genetics Part A 179 (9), 1725-1744, 2019 | 93 | 2019 |
| Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with G aucher disease type 1: The phase 3 ENGAGE trial PK Mistry, E Lukina, H Ben Turkia, SP Shankar, H Baris, M Ghosn, ... American journal of hematology 92 (11), 1170-1176, 2017 | 93 | 2017 |
| Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study DP Germain, E Brand, A Burlina, F Cecchi, SC Garman, J Kempf, ... Molecular genetics & genomic medicine 6 (4), 492-503, 2018 | 89 | 2018 |
| No association between variations in the WDR36 gene and primary open-angle glaucoma JH Fingert, WLM Alward, YH Kwon, SP Shankar, JL Andorf, DA Mackey, ... Archives of ophthalmology 125 (3), 434-436, 2007 | 78 | 2007 |
| Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment EG Shapiro, I Nestrasil, K Rudser, K Delaney, V Kovac, A Ahmed, B Yund, ... Molecular genetics and metabolism 116 (1-2), 61-68, 2015 | 77 | 2015 |
| Oral migalastat HCl leads to greater systemic exposure and tissue levels of active α-galactosidase A in Fabry patients when co-administered with infused agalsidase DG Warnock, DG Bichet, M Holida, O Goker-Alpan, K Nicholls, M Thomas, ... PLoS One 10 (8), e0134341, 2015 | 74 | 2015 |
| Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies P Yu-Wai-Man, SP Shankar, V Biousse, NR Miller, LJH Bean, B Coffee, ... Ophthalmology 118 (3), 558-563, 2011 | 65 | 2011 |
| Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study U Feldt-Rasmussen, D Hughes, G Sunder-Plassmann, S Shankar, ... Molecular genetics and metabolism 131 (1-2), 219-228, 2020 | 59 | 2020 |
| Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial FA Wijburg, B Bénichou, DG Bichet, LA Clarke, G Dostalova, A Fainboim, ... PloS one 10 (5), e0124987, 2015 | 58 | 2015 |
| Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3) NJ Weinreb, DN Finegold, E Feingold, Z Zeng, BE Rosenbloom, ... Orphanet journal of rare diseases 10, 1-16, 2015 | 42 | 2015 |
| Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) R Mao, P Krautscheid, RP Graham, A Ganguly, S Shankar, M Ferber, ... Genetics in Medicine 23 (10), 1807-1817, 2021 | 40 | 2021 |
| Retinoblastoma A Ramasubramanian, CL Shields JP Medical Ltd, 2012 | 39 | 2012 |
Edwin M. StoneUniversity of Iowa, Carver College of Medicine, Department of Ophthalmology and Visual SciencesVerified email at uiowa.edu
